| Day Range2.250 - 2.390 | 52 Wk Range1.830 - 6.010 | Open / Close2.350 / 2.250 | Float / Outstanding45.130M / 55.474M |
| Vol / Avg.266.583K / 160.025K | Mkt Cap124.816M | P/E- | 50d Avg. Price2.600 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float45.130M | EPS-2.290 |
Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Day Range2.250 - 2.390 | 52 Wk Range1.830 - 6.010 | Open / Close2.350 / 2.250 | Float / Outstanding45.130M / 55.474M |
| Vol / Avg.266.583K / 160.025K | Mkt Cap124.816M | P/E- | 50d Avg. Price2.600 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float45.130M | EPS-2.290 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-02 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | -0.580 | -0.1300 | ||||
| REV | 13.430M | 1.921M | -11.509M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.
Who are Cellectis's (CLLS) competitors?
Other companies in Cellectis’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Thursday, January 19, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 166.67% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.25 last updated February 8, 2023 at 9:00 PM UTC.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q4 earnings are confirmed for Thursday, March 2, 2023.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Day Range2.250 - 2.390 | 52 Wk Range1.830 - 6.010 | Open / Close2.350 / 2.250 | Float / Outstanding45.130M / 55.474M |
| Vol / Avg.266.583K / 160.025K | Mkt Cap124.816M | P/E- | 50d Avg. Price2.600 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float45.130M | EPS-2.290 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-02 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | -0.580 | -0.1300 | ||||
| REV | 13.430M | 1.921M | -11.509M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.
Who are Cellectis's (CLLS) competitors?
Other companies in Cellectis’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Thursday, January 19, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 166.67% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.25 last updated February 8, 2023 at 9:00 PM UTC.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q4 earnings are confirmed for Thursday, March 2, 2023.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Day Range2.250 - 2.390 | 52 Wk Range1.830 - 6.010 | Open / Close2.350 / 2.250 | Float / Outstanding45.130M / 55.474M |
| Vol / Avg.266.583K / 160.025K | Mkt Cap124.816M | P/E- | 50d Avg. Price2.600 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float45.130M | EPS-2.290 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-02 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | -0.580 | -0.1300 | ||||
| REV | 13.430M | 1.921M | -11.509M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.
Who are Cellectis's (CLLS) competitors?
Other companies in Cellectis’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Thursday, January 19, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 166.67% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.25 last updated February 8, 2023 at 9:00 PM UTC.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q4 earnings are confirmed for Thursday, March 2, 2023.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Day Range2.250 - 2.390 | 52 Wk Range1.830 - 6.010 | Open / Close2.350 / 2.250 | Float / Outstanding45.130M / 55.474M |
| Vol / Avg.266.583K / 160.025K | Mkt Cap124.816M | P/E- | 50d Avg. Price2.600 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float45.130M | EPS-2.290 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-02 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | -0.580 | -0.1300 | ||||
| REV | 13.430M | 1.921M | -11.509M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.
Who are Cellectis's (CLLS) competitors?
Other companies in Cellectis’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Thursday, January 19, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 166.67% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.25 last updated February 8, 2023 at 9:00 PM UTC.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q4 earnings are confirmed for Thursday, March 2, 2023.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Day Range2.250 - 2.390 | 52 Wk Range1.830 - 6.010 | Open / Close2.350 / 2.250 | Float / Outstanding45.130M / 55.474M |
| Vol / Avg.266.583K / 160.025K | Mkt Cap124.816M | P/E- | 50d Avg. Price2.600 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float45.130M | EPS-2.290 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-02 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | -0.580 | -0.1300 | ||||
| REV | 13.430M | 1.921M | -11.509M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.
Who are Cellectis's (CLLS) competitors?
Other companies in Cellectis’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Thursday, January 19, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 166.67% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.25 last updated February 8, 2023 at 9:00 PM UTC.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q4 earnings are confirmed for Thursday, March 2, 2023.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Day Range2.250 - 2.390 | 52 Wk Range1.830 - 6.010 | Open / Close2.350 / 2.250 | Float / Outstanding45.130M / 55.474M |
| Vol / Avg.266.583K / 160.025K | Mkt Cap124.816M | P/E- | 50d Avg. Price2.600 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float45.130M | EPS-2.290 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-02 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | -0.580 | -0.1300 | ||||
| REV | 13.430M | 1.921M | -11.509M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.
Who are Cellectis's (CLLS) competitors?
Other companies in Cellectis’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Thursday, January 19, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 166.67% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.25 last updated February 8, 2023 at 9:00 PM UTC.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q4 earnings are confirmed for Thursday, March 2, 2023.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Day Range2.250 - 2.390 | 52 Wk Range1.830 - 6.010 | Open / Close2.350 / 2.250 | Float / Outstanding45.130M / 55.474M |
| Vol / Avg.266.583K / 160.025K | Mkt Cap124.816M | P/E- | 50d Avg. Price2.600 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float45.130M | EPS-2.290 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-02 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | -0.580 | -0.1300 | ||||
| REV | 13.430M | 1.921M | -11.509M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.
Who are Cellectis's (CLLS) competitors?
Other companies in Cellectis’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Thursday, January 19, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 166.67% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.25 last updated February 8, 2023 at 9:00 PM UTC.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q4 earnings are confirmed for Thursday, March 2, 2023.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Day Range2.250 - 2.390 | 52 Wk Range1.830 - 6.010 | Open / Close2.350 / 2.250 | Float / Outstanding45.130M / 55.474M |
| Vol / Avg.266.583K / 160.025K | Mkt Cap124.816M | P/E- | 50d Avg. Price2.600 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float45.130M | EPS-2.290 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-02 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | -0.580 | -0.1300 | ||||
| REV | 13.430M | 1.921M | -11.509M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.
Who are Cellectis's (CLLS) competitors?
Other companies in Cellectis’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Thursday, January 19, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 166.67% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.25 last updated February 8, 2023 at 9:00 PM UTC.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q4 earnings are confirmed for Thursday, March 2, 2023.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cellectis Stock (NASDAQ:CLLS), Quotes and News Summary
Cellectis Stock (NASDAQ: CLLS) stock price, news, charts, stock research, profile.
| Day Range2.250 - 2.390 | 52 Wk Range1.830 - 6.010 | Open / Close2.350 / 2.250 | Float / Outstanding45.130M / 55.474M |
| Vol / Avg.266.583K / 160.025K | Mkt Cap124.816M | P/E- | 50d Avg. Price2.600 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float45.130M | EPS-2.290 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-02 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | -0.580 | -0.1300 | ||||
| REV | 13.430M | 1.921M | -11.509M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Cellectis (CLLS) stock?
You can purchase shares of Cellectis (NASDAQ: CLLS) through any online brokerage.
Who are Cellectis's (CLLS) competitors?
Other companies in Cellectis’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for Cellectis (CLLS) stock?
The latest price target for Cellectis (NASDAQ: CLLS) was reported by JMP Securities on Thursday, January 19, 2023. The analyst firm set a price target for 6.00 expecting CLLS to rise to within 12 months (a possible 166.67% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Cellectis (CLLS)?
The stock price for Cellectis (NASDAQ: CLLS) is $2.25 last updated February 8, 2023 at 9:00 PM UTC.
Does Cellectis (CLLS) pay a dividend?
There are no upcoming dividends for Cellectis.
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis’s Q4 earnings are confirmed for Thursday, March 2, 2023.
Is Cellectis (CLLS) going to split?
There is no upcoming split for Cellectis.
What sector and industry does Cellectis (CLLS) operate in?
Cellectis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.